[Programs for continuing medical education: B session 7. Progress in treatment for hematologic diseases].
作者信息
Higashihara Masaaki
出版信息
Nihon Naika Gakkai Zasshi. 2014 Mar 10;103(3):717-23. doi: 10.2169/naika.103.717.
PMID:24796142
Abstract
摘要
相似文献
1
[Programs for continuing medical education: B session 7. Progress in treatment for hematologic diseases].
Nihon Naika Gakkai Zasshi. 2014 Mar 10;103(3):717-23. doi: 10.2169/naika.103.717.
2
Future clinical implications for farnesyltransferase inhibitors in hematologic malignancies.法尼基转移酶抑制剂在血液系统恶性肿瘤中的未来临床应用
Semin Hematol. 2002 Jul;39(3 Suppl 2):36-8. doi: 10.1053/shem.2002.35986.
3
Therapeutic epigenetics: an emerging clinical approach to hematologic malignancies.治疗性表观遗传学：血液系统恶性肿瘤的一种新兴临床治疗方法。
Clin Adv Hematol Oncol. 2005 Mar;3(3 Suppl 1):1-10; quiz 11-2.
4
A summer of hematologic science. Highlights from the 45th Annual Meeting of the American Society of Clinical Oncology, the 14th Congress of the European Hematology Association, and the 2009 Pan Pacific Lymphoma Conference.
Clin Adv Hematol Oncol. 2009 Sep;7(9 Suppl 15):1-22; quiz 23-4.
5
Leukemias and plasma cell myeloma.白血病和浆细胞骨髓瘤。
Cancer Chemother Biol Response Modif. 1999;18:268-92.
6
Absence of BRAF V600E mutation in hematologic malignancies excluding hairy-cell leukemia.除毛细胞白血病外的血液系统恶性肿瘤中BRAF V600E突变缺失
Leuk Lymphoma. 2012 Dec;53(12):2498-9. doi: 10.3109/10428194.2012.695777. Epub 2012 Jul 9.
7
[Current status and future perspective of new drugs for hematological malignancies in Japan].[日本血液系统恶性肿瘤新药的现状与未来展望]
Rinsho Ketsueki. 2007 Oct;48(10):1442-52.
8
Multiple myeloma and chronic leukaemias in 2014: improved understanding of disease biology and treatment.2014 年多发性骨髓瘤和慢性白血病：对疾病生物学和治疗的认识的提高。
Nat Rev Clin Oncol. 2015 Feb;12(2):71-2. doi: 10.1038/nrclinonc.2014.216. Epub 2014 Dec 16.
9
10
Targeted therapy for hematologic malignancies.血液系统恶性肿瘤的靶向治疗
Cancer Control. 2005 Apr;12(2):82-90. doi: 10.1177/107327480501200203.
Zotero 插件